Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangling Daiying Biological Engineering is a Chinese biotechnology company specializing in the research, development, and production of veterinary biological products. Based in the Yangling Agricultural High-tech Industries Demonstration Zone, the company focuses on vaccines for livestock, particularly swine and poultry. Its product portfolio includes vaccines for major animal diseases such as Classical Swine Fever and Foot-and-Mouth Disease. The company integrates R&D with large-scale manufacturing to support the animal husbandry industry in China. By maintaining strict GMP standards, it ensures the quality and efficacy of its veterinary biologics for the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangling Daiying Biological Engineering.